Page 155 - Read Online
P. 155

Page 10 of 15                  Dokko et al. Vessel Plus 2022;6:53  https://dx.doi.org/10.20517/2574-1209.2022.11

               did not differ between ViV-TAVR patients with and without POAF/AFL.


               Multivariate predictors of POAF/AFL
               Multivariable regression analysis of predictors of POAF/AFL are shown in [Table 4]. Older age (OR: 1.05,
               95%CI: 1.03-1.07, P < 0.01) and patients with cerebral vascular disease (OR: 2.18, 95%CI: 1.05-4.55, P = 0.04)
               were significant predictors of POAF/AFL. The c-index of this model was 0.686 and the Hosmer and
               Lemeshow Goodness-of-Fit Test p-value was 0.07 (i.e., indicating acceptable calibration).

               Outcomes of r-SAVR and ViV-TAVR patients with POAF/AFL
               The outcomes of r-AVR patients were analyzed and listed by surgery type and POAF/AFL in [Table 3].
               Patients who underwent r-SAVR with POAF/AFL, compared to r-SAVR patients without POAF/AFL, were
               more likely to result in READMIT (22.4% vs. 9.0%, P = 0.02), prolonged ventilation (12.1% vs. 1.1%,
               P = 0.01), cardiac arrest (17.2% vs. 3.4%, P = 0.01), and longer length of stay (mean ± SD: 13.4 ± 11.8 vs.
               9.2 ± 7.3 days, P = 0.02) compared to r-SAVR patients without POAF/AFL. Compared to ViV-TAVR
               patients with no-POAF/AFL, longer length of stay occurred for ViV-TAVR patients with POAF/AFL
               (12.5 + 10.7 vs. 6.8 + 7.6, P = 0.01). Comparing r-SAVR patients with and without POAF/AFL and ViV-
               TAVR patients with and without POAF/AFL, however, there was no difference in the MM composite (P =
               0.37 and 0.39, respectively).


               Multivariate predictors of MM and READMIT
               For either r-SAVR or ViV-TAVR, the results of the multivariable regression model for MM were reported
               in [Table 5]. POAF/AFL was not a significant predictor of MM (P = 0.55). With multivariable associations
               documented (i.e., P < 0.05), however, the variables black race (OR: 4.97, 95%CI: 1.61-15.37, P < 0.01)  and
               Elixhauser score (OR: 1.05, 95%CI: 1.02-1.08, P < 0.01) were associated with increased MM. The c-index of
               the MM predictive model was 0.713 with the Hosmer and Lemeshow Goodness-of-Fit Test P = 0.85.

               As an important resource consumption metric, POAF/AFL (OR: 3.12, 95%CI: 1.46-6.65, P < 0.01) was
               shown to be a significant predictor of READMIT as shown in [Table 6]. The c-index of this READMIT
               model was 0.638. Due to the limited number of READMIT final multivariable models’ degrees of freedom,
               it was not possible to calculate a Hosmer and Lemeshow Goodness-of-Fit test statistic.

               DISCUSSION
               As a novel contribution to the r-AVR literature, this retrospective observational cohort study documented
               the impact of POAF/AFL upon clinical outcomes and resource utilization. With an overall POAF/AFL
               incidence of 41%, this was by far the most common complication found following r-AVR procedures. As
               noted in the prior literature, older age and cerebral vascular disease were predictors of r-AVR
               POAF/AFL  [16,22-26] . Holding other risk factors constant, POAF/AFL was a predictor of READMIT, but not
               predictive of MM. Importantly, however, black patients and Elixhauser score were predictors of MM; thus,
               these “at risk” r-AVR patients deserve future investigation.


               The 41% incidence of POAF/AFL in New York State’s SPARCS is consistent with Ejiofor et al.’s study which
               reported nearly the same rate when comparing postoperative complications between patients who
               underwent r-SAVR and ViV-TAVR in a matched cohort study . In our study, the incidence of POAF/AFL
                                                                    [19]
               was not significantly different between r-AVR procedure types; in part, this may be due to the difference in
               baseline characteristics between patients who underwent r-SAVR and ViV-TAVR.
   150   151   152   153   154   155   156   157   158   159   160